Health Law Update

Home | Health Law Update

<p class="sharedshowtitle">Partner <a href="http://www.bakerlaw.com/LeeHRosebush" target="_blank" rel="noopener">Lee Rosebush</a> and Associate <a href="http://www.bakerlaw.com/LindsayPHolmes" target="_blank" rel="noopener">Lindsay Holmes</a> authored the cover story for the October 2015 issue of the American Health Lawyers Association publication AHLA Connections. In the article, “U.S. Drug Costs and Patient Access Issues in the 21st Century,” they write:</p>

<div class="wb-content">
<blockquote>High drug costs and concerns regarding patient access to expensive medications are not new. In fact, for decades conversations have centered on the limitations that drug costs have on patients’ ability to access such treatments. However, in the past several years, the focus has shifted to specialty pharmaceuticals, which generally are significantly more expensive than other prescription drugs, and the impact that this category of drugs is having on health care spending and patient access, particularly for life-saving medications. This article explores the drug category of specialty pharmaceuticals and addresses several of the cost and access issues associated with these products.</blockquote>
<a class="js-autopdflink" href="https://www.bakerlaw.com/files/uploads/Documents/News/Articles/BUSINESS/2015/AC_Feature_Oct2015.pdf" target="_blank" rel="noopener">Read the article. © American Health Lawyers Association. All rights reserved</a>.

</div>

Rosebush and Holmes Author AHLA Connections Cover Story on U.S. Drug Costs and Patient Access Issues